Cytokinetics (NASDAQ:CYTK) announced plans to offer approximately $500 million of shares of its common stock in an underwritten public offering. Cytokinetics expects to grant the underwriters a 30-day...
Source LinkCytokinetics (NASDAQ:CYTK) announced plans to offer approximately $500 million of shares of its common stock in an underwritten public offering. Cytokinetics expects to grant the underwriters a 30-day...
Source Link
Comments